By using this site, you agree to the Privacy Policy and Terms of Use.
Accept
Apr 15, 2026
Riyadh
  • English
    • العربية (Arabic)
  • About Us
  • Contact Us
  • Submit News
Saudi Likes News™
  • Business
  • Culture
  • Finance
  • Technology
  • Lifestyle
  • Saudi Arabia
  • MENA
  • Press Releases
Font ResizerAa
Saudi Likes News™Saudi Likes News™
Search
  • English
    • العربية (Arabic)
  • Business
  • Culture
  • Finance
  • Technology
  • Lifestyle
  • Saudi Arabia
  • MENA
  • Press Releases
  • About Us
  • Contact Us
  • Submit News
Saudi Likes News™ is part of GroupWeb Media Network. © 2026 GroupWeb Media LLC.
Saudi Likes News™ > Blog > Press Releases > Nucleotide Sugar Synthesis Services Market Strategic Insights Investment in Biopharmaceutical R&D and Academic Research
Press Releases

Nucleotide Sugar Synthesis Services Market Strategic Insights Investment in Biopharmaceutical R&D and Academic Research

Newsroom
Last updated: November 18, 2025 10:17 pm
Newsroom
Published: November 18, 2025
Share
SHARE


InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the “Global Nucleotide Sugar Synthesis Services Market Size, Share & Trends Analysis Report By Type (Small-Scale Synthesis, Medium-Scale Synthesis, and Large-Scale Synthesis), Product Type (Uridine Diphosphate (UDP) Sugars, Cytidine Monophosphate (CMP) Sugars, Guanosine Diphosphate (GDP) Sugars, and Others), Application (Vaccine Preparation, Drug Research & Development (R&D), Genetic Engineering and Cell Therapy, Diagnostics, and Academic Research),-Market Outlook And Industry Analysis 2034″

Global Nucleotide Sugar Synthesis Services Market Size is valued at US$ 440.0 Mn in 2024 and is predicted to reach US$ 1,306.2 Mn by the year 2034 at an 11.7% CAGR during the forecast period for 2025-2034.

 

Get Free Access to Demo Report, Excel Pivot and ToC: https://www.insightaceanalytic.com/request-sample/3275

 

The biotechnology and pharmaceutical sectors depend heavily on the nucleotide sugar synthesis services market, which supplies vital elements for glycobiology research and treatment development. Nucleotide sugars are essential building blocks for the manufacture of glycoconjugates, which are essential for many biological functions, such as immunological responses and cell signaling. The synthesis of nucleotide sugars has become increasingly important as the need for glycan analysis and manipulation grows, especially in the development of monoclonal antibodies and vaccine research.

The nucleotide sugar synthesis services market is driven by the pharmaceutical and biotechnology sectors’ increasing demand for nucleotide sugars, particularly for the manufacturing of viral vectors for gene therapy and antibody-drug conjugates (ADCs). Moreover, the nucleotide sugar synthesis services market is primarily driven by advances in glycobiology research, the rising incidence of chronic illnesses, and the growing adoption of personalized treatment. Additionally, it is anticipated that the trend of outsourcing difficult synthesis processes to specialist suppliers will drive market expansion.

List of Prominent Players in the Nucleotide Sugar Synthesis Services Market:

  • CD BioGlyco
  • Creative Biolabs
  • Jena Bioscience GmbH
  • GenScript Biotech Corporation
  • Peptide Institute, Inc.
  • Eversyn Technologies
  • Oxeltis
  • BOC Sciences
  • Tokyo Future Style, Inc.
  • FUJIMOTO CHEMICALS CO., LTD
  • Thermo Fisher Scientific
  • Merck KGaA
  • Agilent Technologies
  • Eurofins Scientific
  • Twist Bioscience

 

Read Overview Report– https://www.insightaceanalytic.com/report/nucleotide-sugar-synthesis-services-market/3275

 

Market Dynamics:

Drivers-

The growing awareness of the critical role glycosylation plays in biological processes, the developing biopharmaceutical industry, and the growing need for individualized therapy are the main factors driving the growth of the nucleotide sugar synthesis services market. The market is expanding as the number of clinical trials focusing on glycoconjugate-based medicines increases.

Nucleotide sugar synthesis is becoming more affordable and accessible thanks to advances in high-throughput screening and automated synthetic chemistry. This encourages broader application across numerous research and development projects. Additionally, the nucleotide sugar synthesis services market has grown as investment in medication discovery and development programs targeting glycoproteins and glycans has increased, driven by the rising prevalence of chronic diseases globally.

Challenges:

The nucleotide sugar synthesis services market faces several obstacles despite its encouraging trajectory. For small- and medium-sized businesses, the high operating costs of bespoke synthesis pose a challenge, especially for rare or unstable nucleotide sugars. Significant infrastructure and quality assurance procedures are needed for GMP-grade nucleotide sugar manufacturing to comply with regulations. Additionally, the nucleotide sugar synthesis services market growth may also be hampered by low awareness in developing markets and a lack of specialized technical knowledge. Slower adoption in areas with limited resources is partly due to the high cost of procuring enzymes and the need for rigorous analytical validation.

Regional Trends:

The nucleotide sugar synthesis services market was dominated by the North American region in 2024, driven by the presence of major pharmaceutical and biotechnology firms developing drugs and vaccines. The need for tailored nucleotide sugars is largely driven by this region’s well-established research infrastructure and substantial funding for biological research. Due to a strong concentration of biotech companies, academic institutions, and service providers that specialize in glycobiology, the United States leads the region. Additionally, macroeconomic factors, including higher healthcare R&D spending, government support for life sciences, and favorable patent regimes for innovative biosynthetic processes, influence demand in North America.

The nucleotide sugar synthesis services market is expanding at the fastest rate in the Asia Pacific over the forecast period, driven by growing biotech research, expanding medicinal applications, and developing partnerships between CROs and academic institutions. Glycomics research, which uses nucleotide sugars in drug discovery and vaccine development, is receiving significant funding from countries such as China and India.

Additionally, the region’s cost-competitive environment and highly qualified workforce enhance its appeal for providing services globally. China has the largest market share in Asia Pacific due to significant government incentives, rapid expansion of glycoscience R&D, and the presence of sizable bioscience clusters. Moreover, a sizable market for glycosylation-related services is growing as the Asia Pacific transitions to customized medicine and cell-based therapies.

 

Unlock Your GTM Strategy: https://www.insightaceanalytic.com/customization/3275

 

Recent Developments:

  • June 2025: The clinical-stage biotech business CureVac, which is creating a revolutionary class of transformative therapies based on messenger ribonucleic acid (mRNA), has agreed to sell all of its shares to BioNTech.
  • March 2023: The opening of its new GMP-compliant production facility in the Netherlands was announced by GlycoEra, a significant participant in the nucleotide sugar synthesis services market. With the help of this facility, the business will be able to manufacture superior nucleotide sugars for use in the manufacturing of biopharmaceuticals and other medical products.
  • February 2023: In order to create and promote novel nucleotide sugar therapies for the treatment of uncommon genetic illnesses, Enzymatica, a significant participant in the nucleotide sugar synthesis services market, teamed up with Lonza, a global leader in the life sciences industry.

Segmentation of Nucleotide Sugar Synthesis Services Market-

By Type-

  • Small-Scale Synthesis
  • Medium-Scale Synthesis
  • Large-Scale Synthesis

By Product Type –

  • Uridine Diphosphate (UDP) Sugars
  • Cytidine Monophosphate (CMP) Sugars
  • Guanosine Diphosphate (GDP) Sugars
  • Others

By Application-

  • Vaccine Preparation
  • Drug Research & Development (R&D)
  • Genetic Engineering and Cell Therapy
  • Diagnostics
  • Academic Research

By Region-

North America-

  • The US
  • Canada

Europe-

  • Germany
  • The UK
  • France
  • Italy
  • Spain
  • Rest of Europe

Asia-Pacific-

  • China
  • Japan
  • India
  • South Korea
  • South East Asia
  • Rest of Asia Pacific

Latin America-

  • Brazil
  • Argentina
  • Mexico
  • Rest of Latin America

 Middle East & Africa-

  • GCC Countries
  • South Africa
  • Rest of Middle East and Africa

About Us:

InsightAce Analytic is a market research and consulting firm that enables clients to make strategic decisions. Our qualitative and quantitative market intelligence solutions inform the need for market and competitive intelligence to expand businesses. We help clients gain competitive advantage by identifying untapped markets, exploring new and competing technologies, segmenting potential markets and repositioning products. Our expertise is in providing syndicated and custom market intelligence reports with an in-depth analysis with key market insights in a timely and cost-effective manner.

Contact us:

InsightAce Analytic Pvt. Ltd.

Visit: https://www.insightaceanalytic.com/

Tel : +1 607 400-7072

Asia: +91 79 72967118

info@insightaceanalytic.com



Source link

Australia 3PL Market Set to Reach USD 18.76 Billion by 2031, Growing at 4.58% CAGR – Reports Mordor Intelligence
Open Banking Market to Reach 46 billion by 2030, Fueled by Digital Banking, API Adoption and Strengthened Regulatory Frameworks
سائحون عالميون يواجهون 8 تضاريس مختلفة — iCAUR تثبت قدرتها الكلية على كل التضاريس
Retail Pharmacy Market to Reach USD 1.29 Trillion by 2030, Driven by Demographic Shifts and Channel Transformation
من إيران إلى الصين: حلم طالبة طب على طريق الحرير
TAGGED:#Glycobiology#NucleotideSugar#SugarSynthesis
Share This Article
Facebook Whatsapp Whatsapp LinkedIn Telegram Email
Popular News
MENA

JETOUR’s Premium G Series Unveils New Visual Identity “Ridge of Steel” Led by Legendary Designer Paula Scher

Newsroom
Newsroom
April 15, 2026
$128.6 Billion by 2032 — Standalone Headsets Lead the VR Gaming Explosion
$22.4 Billion by 2032 — Why the 32-Inch Format Dominates Smart Homes & Industrial HMIs
$168.5 Billion by 2032 — Unified Commerce Drives the Next-Generation POS Revolution
AI-Powered Digital Freight Brokerage Market Set to Reach $47.2B by 2032

Categories

  • Business
  • Culture
  • Finance
  • Technology
  • Lifestyle
  • Saudi Arabia
  • MENA
  • Press Releases
Saudi Likes News™

About US

Saudi Likes News™ is your premier destination for insightful, timely, and transformative news coverage from the heart of the Kingdom. In association with Arab Newswire™, we provide press release distribution in Saudi Arabia, the Gulf region or the entire Middle East and North Africa (MENA).

Contact Us

  • WhatsApp: +1 832-716-2363
  • Telegram: @groupwebmedia

Share Us

Latest News

JETOUR’s Premium G Series Unveils New Visual Identity “Ridge of Steel” Led by Legendary Designer Paula Scher
April 15, 2026
$128.6 Billion by 2032 — Standalone Headsets Lead the VR Gaming Explosion
April 15, 2026
$22.4 Billion by 2032 — Why the 32-Inch Format Dominates Smart Homes & Industrial HMIs
April 15, 2026
$168.5 Billion by 2032 — Unified Commerce Drives the Next-Generation POS Revolution
April 15, 2026
  • العربية (Arabic)
  • English
Saudi Likes News™ is part of GroupWeb Media Network. © 2026 GroupWeb Media LLC.
  • About Us
  • Contact Us
  • Submit News
Welcome Back!

Sign in to your account

Username or Email Address
Password

Lost your password?